Author:
Baughman Robert P,Meyer Keith C,Nathanson Ian,Angel Luis,Bhorade Sangeeta M,Chan Kevin M,Culver Daniel,Harrod Christopher G,Hayney Mary S,Highland Kristen B,Limper Andrew H,Patrick Herbert,Strange Charlie,Whelan Timothy
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference595 articles.
1. A high-yield strategy to identify randomized controlled trials for systematic reviews;Jadad;Online J Curr Clin Trials,1993
2. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
3. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis);Furst;J Rheumatol,2003
4. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study;Weinblatt;Ann Rheum Dis,2006
5. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial;Weinblatt;Arthritis Rheum,2003
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献